From polymers to nanomedicines: New materials for future vaccines

Molecular Vaccines: From Prophylaxis to Therapy - Volume 2

Volumn , Issue , 2014, Pages 643-671

  Heller, Philipp ^a   Huesmann, David ^a   Scherer, Martin ^a   Barz, Matthias ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84957697326     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-00978-0_15     Document Type: Chapter

References (258)

1. Duffus, J.H., Nordberg, M., Templeton, D.M.: Glossary of terms used in toxicology, 2nd edition (IUPAC Recommendations 2007). Pure Appl. Chem. 79, 1153-1344 (2007)
2. Duncan, R., Gaspar, R.: Nanomedicine(s) under the microscope. Mol. Pharm. 8, 2101-2141 (2011)
3. Johnston, A.P.R., Such, G.K., Ng, S.L., Caruso, F.: Challenges facing colloidal delivery systems: from synthesis to the clinic. Curr. Opin. Colloid In. 16, 171-181 (2011)
4. Torchilin, V.P.: Micellar nanocarriers: pharmaceutical perspectives. Pharm. Res. 24, 1-16 (2007)
5. Lasic, D.D., Martin, F.J.: Stealth Liposomes. CRC Press, Boca Raton (1995)
6. Hobbs, S.K., et al.: Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl. Acad. Sci. U. S. A. 95, 4607-4612 (1998)
7. Torchilin, V.P.: Targeted polymeric micelles for delivery of poorly soluble drugs. Cell. Mol. Life Sci. 61, 2549-2559 (2004)
8. Nagasaki, Y., Yasugi, K., Yamamoto, Y., Harada, A., Kataoka, K.: Sugar-installed block copolymer micelles: their preparation and specific interaction with lectin molecules. Biomacromolecules 2, 1067-1070 (2001)
9. Ogris, M., Brunner, S., Schuller, S., Kircheis, R., Wagner, E.: PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6, 595-605 (1999)
10. Leamon, C.P., Weigl, D., Hendren, R.W.: Folate copolymer-mediated transfection of cultured cells. Bioconjug. Chem. 10, 947-957 (1999)
11. Hopewell, J.W., Duncan, R., Wilding, D., Chakrabarti, K.: Preclinical evaluation of the cardiotoxicity of PK2: a novel HPMA copolymer-doxorubicin-galac-tosamine conjugate antitumour agent. Hum. Exp. Toxicol. 20, 461-470 (2001)
12. Ahmed, F., et al.: Shrinkage of a rapidly growing tumor by drug-loaded polymersomes: pH-triggered release through copolymer degradation. Mol. Pharm. 3, 340-350 (2006)
13. Saito, G., Swanson, J.A., Lee, K.-D.: Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv. Drug Deliv. Rev. 55, 199-215 (2003)
14. Thornton, P.D., Mart, R.J., Webb, S.J., Ulijn, R.V.: Enzyme-responsive hydrogel particles for the controlled release of proteins: designing peptide actuators to match payload. Soft Matter 4, 821-827 (2008)
15. Ishida, O., Maruyama, K., Yanagie, H., Iwatsuru, M., Eriguchi, M.: Targeting chemotherapy to solid tumors with long circulating thermosensitive liposomes and local hyperthermia. Jpn. J. Cancer Res. 91, 118-126(2000)
16. Edelman, E.R., Kost, J., Bobeck, H., Langer, R.: Regulation of drug release from polymer matrices by oscillating magnetic fields. J. Biomed. Mater. Res. 19, 67-83 (1985)
17. Langer, R.: New methods of drug delivery. Science 249, 1527-1533 (1990)
18. Uhrich, K.E., Cannizzaro, S.M., Langer, R.S., Shakesheff, K.M.: Polymeric systems for controlled drug release. Chem. Rev. 99, 3181-3198 (1999)
19. Little, S.R.: Reorienting our view of particle-based adjuvants for subunit vaccines. Proc. Natl. Acad. Sci. 109, 999-1000 (2012)
20. Moon, J.J., et al.: Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction. Proc. Natl. Acad. Sci. U. S. A. 109, 1080-1085 (2012)
21. Prokop, A., Davidson, J.M.: Nanovehicular intracellular delivery systems. J. Pharm. Sci. 97, 3518-3590 (2008)
22. Gref, R., et al.: Biodegradable long-circulating polymeric nanospheres. Science 263, 1600-1603 (1994)
23. Owens, D.E., Peppas, N.A.: Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307, 93-102 (2006)
24. Frank, M., Fries, L.: The role of complement in inflammation and phagocytosis. Immunol. Today 12, 322-326 (1991)
25. Johnson, R.J.: The complement system. In: Ratner, B.D., Hoffman, A.S., Schoen, F.J., Lemons, J.E. (eds.) Biomaterials Science: An Introduction to Materials in Medicine, pp. 318-328. Elsevier/Academic, Amsterdam (2004)
26. Ostuni, E., Chapman, R.G., Holmlin, R.E., Takayama, S., Whitesides, G.M.: A survey of structure-property relationships of surfaces that resist the adsorption of protein. Langmuir 17, 5605-5620 (2001)
27. Scheibe, P., Barz, M., Hemmelmann, M., Zentel, R.: Langmuir-Blodgett films of biocompatible poly (HPMA)-block-poly(lauryl methacrylate) and poly(HPMA)-random-poly(lauryl methacrylate): influence of polymer structure on membrane formation and stability. Langmuir 26, 5661-5669 (2010)
28. Kelsch, A., et al.: HPMA copolymers as surfactants in the preparation of biocompatible nanoparticles for biomedical application. Biomacromolecules 13, 4179-4187 (2012)
29. Riess, G.: Micellization of block copolymers. Prog. Polym. Sci. 28, 1107-1170 (2003)
30. O’Reilly, R.K., Hawker, C.J., Wooley, K.L.: Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility. Chem. Soc. Rev. 35, 1068-1083 (2006)
31. Kabanov, A.V, Vinogradov, S.V: Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angew. Chem. Int. Ed. Engl. 48, 5418-5429 (2009)
32. Christie, R.J., Nishiyama, N., Kataoka, K.: Delivering the code: polyplex carriers for deoxyribonucleic acid and ribonucleic acid interference therapies. Endocrinology 151, 466-473 (2010)
33. Miyata, K., Nishiyama, N., Kataoka, K.: Rational design of smart supramolecular assemblies for gene delivery: chemical challenges in the creation of artificial viruses. Chem. Soc. Rev. 41, 2562-2574 (2012)
34. Kataoka, K., Harada, A., Nagasaki, Y.: Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Deliv. Rev. 47, 113-131 (2001)
35. Torchilin, V.P.: Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Release 73, 137-172 (2001)
36. Gaucher, G., et al.: Block copolymer micelles: preparation, characterization and application in drug delivery. J. Control. Release 109, 169-188 (2005)
37. Nuhn, L., et al.: Cationic nanohydrogel particles as potential siRNA carriers for cellular delivery. ACS Nano 6, 2198-2214 (2012)
38. Fleige, E., Quadir, M.A., Haag, R.: Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Adv. Drug Deliv. Rev. 64, 866-884 (2012)
39. Jesorka, A., Orwar, O.: Liposomes: technologies and analytical applications. Annu. Rev. Anal. Chem. 1, 801-832 (2008)
40. Torchilin, V.P.: Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4, 145-160 (2005)
41. Szoka, F.C.: Comparative properties and methods of preparation of lipid vesicles (liposomes). Ann. Rev. Biophys. Bioeng. 9, 467-508 (1980)
42. Lasic, D.D.: Sterically stabilized vesicles. Angew. Chem. Int. Ed. Engl. 33, 1685-1698 (1994)
43. Allen, T.M., Cullis, P.R.: Drug delivery systems: entering the mainstream. Science 303, 1818-1822 (2004)
44. White, K.L., Rades, T., Furneaux, R.H., Tyler, P.C., Hook, S.: Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells. J. Pharm. Pharmacol. 58, 729-737 (2006)
45. Drummond, D.C., Meyer, O., Hong, K., Kirpotin, D.B., Papahadjopoulos, D.: Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 51, 691-744 (1999)
46. Krishnamachari, Y., Geary, S.M., Lemke, C.D., Salem, A.K.: Nanoparticle delivery systems in cancer vaccines. Pharm. Res. 28, 215-236 (2011)
47. Gluck, R.: Immunopotentiating reconstituted influenza virosomes (IRIVs) and other adjuvants for improved presentation of small antigens. Vaccine 10, 915-919 (1992)
48. Moser, C., et al.: Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations. Expert Rev. Vaccines6, 711-721 (2007)
49. Kayser, O., Olbrich, C., Croft, S.L., Kiderlein, A.F.: Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs. Parasitol. Res. 90, S63-S70 (2003)
50. Discher, D.E., Ahmed, F.: Polymersomes. Annu. Rev. Biomed. Eng. 8, 323-341 (2006)
51. Levine, D.H., et al.: Polymersomes: a new multifunctional tool for cancer diagnosis and therapy. Methods 46, 25-32 (2008)
52. Osterhaus, A., Rimmelzwaan, G.F.: Induction of virus-specific immunity by ISCOMs. Dev. Biol. Stand. 92, 49-58 (1998)
53. Saupe, A., McBurney, W., Rades, T., Hook, S.: Immunostimulatory colloidal delivery systems for cancer vaccines. Expert Opin. Drug Deliv. 3, 345-354 (2006)
54. Westesen, K., Siekmann, B.: Biodegradable colloidal drug carrier systems based on solid lipids. In: Benita, S. (ed.) Microencapsulation, pp. 213-258. Marcel Dekker, New York (1996)
55. Bunjes, H.: Lipid nanoparticles for the delivery of poorly water-soluble drugs. J. Pharm. Pharmacol. 62, 1637-1645 (2010)
56. Petersen, S., Steiniger, F., Fischer, D., Fahr, A., Bunjes, H.: The physical state of lipid nanoparticles affects their in vitro cell viability. Eur. J. Pharm. Biopharm. 79, 150-161 (2011)
57. Shi, R., et al.: Enhanced immune response to gastric cancer specific antigen peptide by coencapsulation with CpG oligodeoxynucleotides in nanoemulsion. Cancer Biol. Ther. 4, 218-242 (2005)
58. Gupta, S., Moulik, S.P.: Biocompatible microemulsions and their prospective uses in drug delivery. J. Pharm. Sci. 97, 22-45 (2008)
59. Fanun, M.: Microemulsions as delivery systems. Curr. Opin. Colloid In. 17, 306-313 (2012)
60. Sailaja, A.K., Amareshwar, R, Chakravarty, P.: Chitosan nanoparticles as a drug delivery system. Res. J. Pharm. Biol. Chem. Sci. 1, 474-484 (2010)
61. Lohse, S.E., Murphy, C.J.: Applications of colloidal inorganic nanoparticles: from medicine to energy. J. Am. Chem. Soc. 134, 15607-15620 (2012)
62. Landfester, K.: Synthesis of colloidal particles in miniemulsions. Annu. Rev. Mater. Res. 36, 231-279 (2006)
63. Klinger, D., Landfester, K.: Stimuli-responsive microgels for the loading and release of functional compounds: Fundamental concepts and applications. Polymer 53, 5209-5231 (2012)
64. Ugelstad, J., Mork, P.C., Kaggerud, K.H., Ellingsen, T., Berge, A.: Swelling of oligomer-polymer particles: new method of preparation of emulsions and polymer dispersions. Adv. Colloid Interface Sci. 13, 101-140 (1980)
65. Chern, C.S., Chen, TJ., Liou, Y.C.: Miniemulsion polymerization of styrene in the presence of a water-insoluble blue dye. Polymer 37, 3767-3777 (1998)
66. Reimers, J.L., Schork, F.J.: Lauroyl peroxide as a cosurfactant in miniemulsion polymerization. Ind. Eng. Chem. Res. 36, 1085-1087 (1997)
67. Landfester, K.: Recent developments in miniemulsions-formation and stability mechanisms. Macromol. Symp. 150, 171-178 (2000)
68. Tamber, H., Johansen, R, Merkle, H.P., Gander, B.: Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv. Drug Deliv. Rev. 57, 357-376 (2005)
69. Mok, H., Park, T.G.: Direct plasmid DNA encapsulation within PLGA nanospheres by single oil-inwater emulsion method. Eur. J. Pharm. Biopharm. 68, 105-111 (2008)
70. Meyer, J.D., Manning, M.C.: Hydrophobic ion pairing: altering the solubility properties of biomolecules. Pharm. Res. 15, 188-193 (1998)
71. Kazzaz, J., Neidleman, J., Singh, M., Ott, G., O’Hagan, D.T.: Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1. J. Control. Release 67, 347-356 (2000)
72. Schwendeman, S.P.: Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. Crit. Rev. Ther. Drug Carr. Syst. 19, 73-98 (2002)
73. Barz, M., et al.: Synthesis, characterization and preliminary biological evaluation of P(HPMA)-b-P(LLA) copolymers: a new type of functional biocompatible block copolymer. Macromol. Rapid Comm. 31, 1492-1500 (2010)
74. Barz, M., et al.: P(HPMA)-block-P(LA) copolymers in paclitaxel formulations: polylactide stereochemistry controls micellization, cellular uptake kinetics, intracellular localization and drug efficiency. J. Control. Release 163, 63-74 (2012)
75. Aspinall, G.O.: The Polysaccharides 35. Academic, New York (1982)
76. Leonard, M., et al.: Preparation of polysaccharide-covered polymeric nanoparticles by several processes involving amphiphilic polysaccharides. ACS Symp. Ser. 996, 322-340 (2008)
77. Artursson, R, Lindmark, T., Davis, S., Illum, L.: Effect of chitosan on the permeability of monolayers of intestinal epithelial-cells (Caco-2). Pharm. Res. 11, 1358-1361 (1994)
78. Domard, A., Gey, C., Rinaudo, M., Terrassin, C., et al.: C-13 and H-1-NMR spectroscopy of chitosan and Ntrimethyl chloride derivates. Int. J. Biol. Macromol. 9, 233-237 (1987)
79. Sundar, S., Kundu, J., Kundu, S.C.: Biopolymeric nanoparticles. Sci. Technol. Adv. Mater. (11) (2010)
80. Schultze, V., et al.: Safety of MF59(TM) adjuvant. Vaccine 26, 3209-3222 (2008)
81. Makidon, P.E., et al.: Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine. PLoS One 3, e2954 (2008)
82. Bielinska, A.U., et al.: Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates. AIDS Res. Hum. Retrov. 24, 271-281 (2008)
83. Ge, W., et al.: The antitumor immune responses induced by nanoemulsion encapsulated MAGE1-HSP70/SEA complex protein vaccine following different administration routes. Oncol. Rep. 22, 915-920 (2009)
84. Rolland, J.P., et al.: Direct fabrication and harvesting of monodisperse. Shape-specific nanobiomaterials. J. Am. Chem. Soc. 127, 10096-10100 (2005)
85. Gratton, S.E., et al.: Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles. J. Control. Release 121, 10-18 (2007)
86. Dunn, S.S., et al.: Reductively responsive siRNA-conjugated hydrogel nanoparticles for gene silencing. J. Am. Chem. Soc. 134, 7423-7430 (2012)
87. Laurent, S., et al.: Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 108, 2064-2110 (2008)
88. Dahl, J.A., Maddux, B.L.S., Hutchison, J.E.: Toward greener nanosynthesis. Chem. Rev. 107, 2228-2269 (2007)
89. Caragheorgheopol, A., Chechik, V.: Mechanistic aspects of ligand exchange in Au nanoparticles. Phys. Chem. Chem. Phys. 10, 5029-5041 (2008)
90. Bernardi, R.J., Lowery, A.R., Thompson, P.A., Blaney, S.M., West, J.L.: Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines. J. Neurooncol 86, 165-172 (2008)
91. Cruz, L.J., et al.: Targeting nanosystems to human DCs via Fc receptor as an effective strategy to deliver antigen for immunotherapy. Mol. Pharm. 8, 104-116 (2011)
92. Ito, A., Honda, H., Kobayashi, T.: Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of “heat-controlled necrosis” with heat shock protein expression. Cancer Immunol. Immunother. 55, 320-328 (2006)
93. Masoudi, A., Madaah Hosseini, H.R., Shokrgozar, M.A., Ahmadi, R., Oghabian, M.A.: The effect of poly(ethylene glycol) coating on colloidal stability of superparamagnetic iron oxide nanoparticles as potential MRI contrast agent. Int. J. Pharm. 433, 129-141(2012)
94. Webster, R. et al.: PEG and PEG conjugates toxicity: towards an understanding of the toxicity of PEG and its relevance to PEGylated biologicals. In: PEGylated Protein Drugs: Basic Science and Clinical Applications. Birkhäuser Verlag, Basel (2009) pp. 127-146
95. Bendele, A., Seely, J., Richey, C., Sennello, G., Shopp, G.: Short communication: renal tubular vac-uolation in animals treated with polyethyleneglycol-conjugated proteins. Toxicol. Sci. 42, 152-157 (1998)
96. Young, M.A., Malavalli, A., Winslow, N., Vandegriff, K.D., Winslow, R.M.: Toxicity and hemodynamic effects after single dose administration of MalPEG-hemoglobin (MP4) in rhesus monkeys. Transl. Res. 149, 333-342 (2007)
97. Chapman, R.G., et al.: Surveying for surfaces that resist the adsorption of proteins. J. Am. Chem. Soc. 122, 8303-8304 (2000)
98. Zhou, M., et al.: High throughput discovery of new fouling-resistant surfaces. J. Mater. Chem. 21, 693 (2011)
99. Fasting, C., et al.: Multivalency as a chemical organization and action principle. Angew. Chem. Int. Ed. Engl. 51, 10472-10498 (2012)
100. Niederhafner, P., Reinis, M., Sebestik, J., Jezek, J.: Glycopeptide dendrimers, part III: a review. Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases. J. Pept. Sci. 14, 556-587 (2008)
101. Günay, K.A., Theato, P., Klok, H.A.: Standing on the shoulders of Hermann Staudinger: post polymerization modification from past to present. J. Polym. Sci. A1 51, 1-28 (2013)
102. Grandjean, C., Boutonnier, A., Guerreiro, C., Fournier, J.-M., Mulard, L.A.: On the preparation of carbohydrate-protein conjugates using the traceless Staudinger ligation. J. Org. Chem. 70, 7123-7132 (2005)
103. Xu, P., et al.: Simple, direct conjugation of bacterial O-SP-core antigens to proteins: development of cholera conjugate vaccines. Bioconjugate Chem. 22, 2179-2185 (2011)
104. Scaramuzza, S., et al.: A new site-specific monoPE-Gylated filgrastim derivative prepared by enzymatic conjugation: production and physicochemical characterization. J. Control. Release 164, 355-363 (2012)
105. Jung, B., Theato, P.: Chemical strategies for the synthesis of protein-polymer conjugates. Bio-synth. Polym. Conjugates 253, 37-70 (2013)
106. Moad, G., Rizzardo, E., Thang, S.H.: Living radical polymerization by the RAFT process. Aust. J. Chem. 58, 379 (2005)
107. Moad, G., Rizzardo, E., Thang, S.H.: Radical addition-fragmentation chemistry in polymer synthesis. Polymer 49, 1079-1131 (2008)
108. Braunecker, W.A., Matyjaszewski, K.: Controlled/living radical polymerization: features, developments, and perspectives. Prog. Polym. Sci. 32, 93-146 (2007)
109. Matyjaszewski, K., Xia, J.: Atom transfer radical polymerization. Chem. Rev. 101, 2921-2990 (2001)
110. York, A.W., Kirkland, S.E., McCormick, C.L.: Advances in the synthesis of amphiphilic block copolymers via RAFT polymerization: stimuli-responsive drug and gene delivery. Adv. Drug Deliv. Rev. 60, 1018-1036 (2008)
111. Gao, H., Matyjaszewski, K.: Synthesis of functional polymers with controlled architecture by CRP of monomers in the presence of cross-linkers: from stars to gels. Prog. Polym. Sci. 34, 317-350 (2009)
112. Marsden, H.R., Kros, A.: Polymer-peptide block copolymers-an overview and assessment of synthesis methods. Macromol. Biosci. 9, 939-951 (2009)
113. Tizzotti, M., Charlot, A., Fleury, E., Stenzel, M., Bernard, J.: Modification of polysaccharides through controlled/living radical polymerization grafting-towards the generation of high performance hybrids. Macromol. Rapid Comm. 31, 1751-1772 (2010)
114. Lutz, J.F.: Polymerization of oligo(ethylene glycol) (meth)acrylates: toward new generations of smart biocompatible materials. J. Polym. Sci. A1 46, 3459-3470 (2008)
115. Lutz, J.-F., Akdemir, O., Hoth, A.: Point by point comparison of two thermosensitive polymers exhibiting a similar LCST: is the age of poly(NIPAM) over? J. Am. Chem. Soc. 128, 13046-13047 (2006)
116. Tao, L., Mantovani, G., Lecolley, F., Haddleton, D.M.: Alpha-aldehyde terminally functional meth-acrylic polymers from living radical polymerization: application in protein conjugation “pegylation”. J. Am. Chem. Soc. 126, 13220-13221 (2004)
117. Lutz, J.-F., Hoth, A.: Preparation of Ideal PEG analogues with a tunable thermosensitivity by controlled radical copolymerization of 2-(2-Methoxyethoxy) ethyl methacrylate and oligo(ethylene glycol) methacrylate. Macromolecules 39, 893-896 (2006)
118. Ryan, S.M., et al.: Conjugation of salmon calcitonin to a combed-shaped end functionalized poly(poly(ethylene glycol) methyl ether methacrylate) yields a bioactive stable conjugate. J. Control. Release 135, 51-59 (2009)
119. Lutz, J.-F., Andrieu, J., Üzgün, S., Rudolph, C., Agarwal, S.: Biocompatible, thermoresponsive, and biodegradable: simple preparation of “all-in-one” biorelevant polymers. Macromolecules 40, 8540-8543 (2007)
120. Ishihara, K., Ziats, N.P., Tierney, B.P., Nakabayashi, N., Anderson, J.M.: Protein adsorption from human plasma is reduced on phospholipid polymers. J. Biomed. Mater. Res. A 25, 1397-1407 (1991)
121. Salvage, J.P., et al.: Novel biocompatible phosphorylcholine-based self-assembled nanoparticles for drug delivery. J. Control. Release 104, 259-270 (2005)
122. Murdoch, C., et al.: Internalization and biodistribution of polymersomes into oral squamous cell carcinoma cells in vitro and in vivo. Nanomedicine 5, 1025-1036 (2010)
123. Lomas, H., et al.: Non-cytotoxic polymer vesicles for rapid and efficient intracellular delivery. Faraday Discuss. 139, 143-159 (2008)
124. Lewis, A., Tang, Y., Brocchini, S., Choi, J.-W., Godwin, A.: Poly(2-methacryloyloxyethyl phos-phorylcholine) for protein conjugation. Bioconjugate Chem. 19, 2144-2155 (2008)
125. Kopecek, J., Kopeckova, P.: HPMA copolymers: origins, early developments, present, and future. Adv. Drug Deliv. Rev. 62, 122-149 (2010)
126. Barz, M., et al.: From defined reactive diblock copolymers to functional HPMA-based self-assembled nanoaggregates. Biomacromolecules 9, 3114-3118 (2008)
127. Barz, M., Canal, F., Koynov, K., Zentel, R., Vicent, M.J.: Synthesis and in vitro evaluation of defined HPMA folate conjugates: influence of aggregation on folate receptor (FR) mediated cellular uptake. Biomacromolecules 11, 2274-2282 (2010)
128. Leuchs, H.: Über die Glycin-carbonsäure. Ber. Dtsch. Chem. Ges. 39, 857-861 (1906)
129. Kricheldorf, H.R.: a-Amino acid-N-Carboxy-Anhydrides and Related Heterocycles: Syntheses, Properties, Peptide Synthesis, Polymerization. Springer, Berlin/Heidelberg/New York (1987)
130. Kricheldorf, H.R.: Polypeptides and 100 years of chemistry of alpha-amino acid N-carboxyanhydrides. Angew. Chem. Int. Ed. Engl. 45, 5752-5784 (2006)
131. Hadjichristidis, N., Iatrou, H., Pitsikalis, M., Sakellariou, G.: Synthesis of well-defined polypeptide-based materials via the ring-opening polymerization of alpha-amino acid N-carboxyanhydrides. Chem. Rev. 109, 5528-5578 (2009)
132. Bogdanov, A.A., et al.: A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. Radiology 187, 701-706 (1993)
133. Singer, J.W., et al.: Paclitaxel poliglumex (XYOTAX; CT-2103): an intracellularly targeted taxane. Anticancer Drug. 16, 243-254 (2005)
134. Harada, A., Kataoka, K.: Formation of polyion complex micelles in an aqueous milieu from a pair of oppositely-charged block copolymers with poly(ethylene glycol) segments. Macromolecules 28, 5294-5299 (1995)
135. Carlsen, A., Lecommandoux, S.: Self-assembly of polypeptide-based block copolymer amphiphiles. Curr. Opin. Colloid In. 14, 329-339 (2009)
136. Deng, J., et al.: Self-assembled cationic micelles based on PEG-PLL-PLLeu hybrid polypeptides as highly effective gene vectors. Biomacromolecules 13, 3795-3804 (2012)
137. Bellomo, E.G., Wyrsta, M.D., Pakstis, L., Pochan, D.J., Deming, TJ.: Stimuli-responsive polypeptide vesicles by conformation-specific assembly. Nat. Mater. 3, 244-248 (2004)
138. Holowka, E.P., Sun, V.Z., Kamei, D.T., Deming, T.J.: Polyarginine segments in block copolypeptides drive both vesicular assembly and intracellular delivery. Nat. Mater. 6, 52-57 (2007)
139. Kanzaki, T., Horikawa, Y., Makino, A., Sugiyama, J., Kimura, S.: Nanotube and three-way nanotube formation with nonionic amphiphilic block peptides. Macromol. Biosci. 8, 1026-1033 (2008)
140. Nowak, A.P., et al.: Rapidly recovering hydrogel scaffolds from self-assembling diblock copolypeptide amphiphiles. Nature 417, 424-428 (2002)
141. Takae, S., et al.: PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors. J. Am. Chem. Soc. 130, 6001-6009 (2008)
142. Uchida, H., et al.: Odd-even effect of repeating ami-noethylene units in the side chain of N-substituted polyaspartamides on gene transfection profiles. J. Am. Chem. Soc. 133, 15524-15532 (2011)
143. Sanjoh, M., et al.: Dual environment-responsive polyplex carriers for enhanced intracellular delivery of plasmid DNA. Biomacromolecules 13, 3641-3649 (2012)
144. Naito, M., et al.: A phenylboronate-functionalized polyion complex micelle for ATP-triggered release of siRNA. Angew. Chem. Int. Ed. Engl. 124, 10909-10913 (2012)
145. Hamaguchi, T., et al.: NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. Brit. J. Cancer 92, 1240-1246 (2005)
146. Weissleder, R., Tung, C.H., Mahmood, U., Bogdanov, A.: In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat. Biotechnol. 17, 375-378 (1999)
147. Arnon, R.: The development of Cop 1 (Copaxone), an innovative drug for the treatment of multiple sclerosis: personal reflections. Immunol. Lett. 50, 1-15 (1996)
148. Shaffer, S.A., et al.: In vitro and in vivo metabolism of paclitaxel poliglumex: identification of metabolites and active proteases. Cancer Chemother. Pharmacol. 59, 537-548 (2007)
149. Hanson, J.A., et al.: Nanoscale double emulsions stabilized by single-component block copolypeptides. Nature 455, 85-88 (2008)
150. Matsumura, Y.: Poly (amino acid) micelle nanocarriers in preclinical and clinical studies. Adv. Drug Deliv. Rev. 60, 899-914 (2008) http://www.clinicaltrials.gov.
151. Li, C., Wallace, S.: Polymer-drug conjugates: recent development in clinical oncology. Adv. Drug Deliv. Rev. 60, 886-898 (2008)
152. Wilms, D., Stiriba, S.-E., Frey, H.: Hyperbranched polyglycerols: from the controlled synthesis of biocompatible polyether polyols to multipurpose applications. Acc. Chem. Res. 43, 129-141 (2010)
153. Quadir, M.A., Haag, R.: Biofunctional nanosystems based on dendritic polymers. J. Control. Release 161, 484-495 (2012)
154. Khandare, J., Calderon, M., Dagia, N.M., Haag, R.: Multifunctional dendritic polymers in nanomedicine: opportunities and challenges. Chem. Soc. Rev. 41, 2824-2848 (2012)
155. Mourey, T.H., et al.: Unique behavior of dendritic macromolecules: intrinsic viscosity of polyether dendrimers. Macromolecules 25, 2401-2406 (1992)
156. Wyszogrodzka, M., Haag, R.: Study of single protein adsorption onto monoamino oligoglycerol derivatives: a structure-activity relationship. Langmuir 25, 5703-5712 (2009)
157. Wyszogrodzka, M., et al.: New approaches towards monoamino polyglycerol dendrons and dendritic triblock amphiphiles. Eur. J. Org. Chem. 2008, 53-63 (2008)
158. Haag, R., Sunder, A., Stumbé, J.-F.: An approach to glycerol dendrimers and pseudo-dendritic polyglycerols. J. Am. Chem. Soc. 122, 2954-2955 (2000)
159. Sunder, A., Krämer, M., Hanselmann, R., Mülhaupt, R., Frey, H.: Molecular nanocapsules based on amphiphilic hyperbranched polyglycerols. Angew. Chem. Int. Ed. Engl. 38, 3552-3555 (1999)
160. Wilms, D., et al.: Hyperbranched polyglycerols with elevated molecular weights: a facile two-step synthesis protocol based on polyglycerol macroinitiators. Macromolecules 42, 3230-3236 (2009)
161. Barriau, E., et al.: Systematic investigation of functional core variation within hyperbranched polyglycerols. J. Polym. Sci. A1 46, 2049-2061 (2008)
162. Roller, S., Zhou, H., Haag, R.: High-loading polyglycerol supported reagents for Mitsunobu- and acylation-reactions and other useful polyglycerol derivatives. Mol. Divers. 9, 305-316 (2005)
163. Kainthan, R.K., Janzen, J., Levin, E., Devine, D.V., Brooks, D.E.: Biocompatibility testing of branched and linear polyglycidol. Biomacromolecules 7, 703-709 (2006)
164. Kainthan, R.K., Hester, S.R., Levin, E., Devine, D.V., Brooks, D.E.: In vitro biological evaluation of high molecular weight hyperbranched polyglycerols. Biomaterials 28, 4581-4590 (2007)
165. Kainthan, R.K., Brooks, D.E.: In vivo biological evaluation of high molecular weight hyperbranched polyglycerols. Biomaterials 28, 4779-4787 (2007)
166. Calderon, M., Quadir, M.A., Sharma, S.K., Haag, R.: Dendritic polyglycerols for biomedical applications. Adv. Mater. 22, 190-218 (2010)
167. Calderon, M., Graeser, R., Kratz, F., Haag, R.: Development of enzymatically cleavable prodrugs derived from dendritic polyglycerol. Bioorg. Med. Chem. Lett. 19, 3725-3728 (2009)
168. Calderon, M., et al.: Development of efficient acid cleavable multifunctional prodrugs derived from dendritic polyglycerol with a poly(ethylene glycol) shell. J. Control. Release 151, 295-301 (2011)
169. Papp, I., Dernedde, J., Enders, S., Haag, R.: Modular synthesis of multivalent glycoarchitectures and their unique selectin binding behavior. Chem. Commun. 4, 5851-5853 (2008)
170. Türk, H., Haag, R., Alban, S.: Dendritic polyglycerol sulfates as new heparin analogues and potent inhibitors of the complement system. Bioconjug. Chem. 15, 162-167 (2003)
171. Dernedde, J., et al.: Dendritic polyglycerol sulfates as multivalent inhibitors of inflammation. Proc. Natl. Acad. Sci. U. S. A. 44, 19679-19684 (2010)
172. Steinhilber, D., et al.: Synthesis, reductive cleavage, and cellular interaction studies of biodegradable polyglycerol nanogels. Adv. Funct. Mater. 20, 4133-4138 (2010)
173. Sisson, A.L., et al.: Biocompatible functionalized polyglycerol microgels with cell penetrating properties. Angew. Chem. Int. Ed. Engl. 48, 7540-7545 (2009)
174. Sisson, A.L., Papp, I., Landfester, K., Haag, R.: Functional nanoparticles from dendritic precursors: hierarchical assembly in miniemulsion. Macromolecules 42, 556-559 (2009)
175. Luxenhofer, R., et al.: Poly(2-oxazoline)s as polymer therapeutics. Macromol. Rapid Comm. 33, 1613-1631 (2012)
176. Viegas, T.X., et al.: Polyoxazoline: chemistry, properties, and applications in drug delivery. Bioconjugate Chem. 22, 976-986 (2011)
177. Knop, K., Hoogenboom, R., Fischer, D., Schubert, U.S.: Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew. Chem. Int. Ed. Engl. 49, 6288-6308 (2010)
178. Kempe, K., et al.: Multifunctional poly(2-oxazoline) nanoparticles for biological applications. Macromol. Rapid Comm. 31, 1869-1873 (2010)
179. Luxenhofer, R., et al.: Structure-property relationship in cytotoxicity and cell uptake of poly(2-oxazoline) amphiphiles. J. Control. Release 153, 73-82 (2011)
180. Donev, R., Koseva, N., Petrov, P., Kowalczuk, A., Thome, J.: Characterisation of different nanoparticles with a potential use for drug delivery in neuropsychiatric disorders. World J. Biol. Psychiatry 12, 44-51 (2011)
181. Tong, J., et al.: Neuronal uptake and intracellular superoxide scavenging of a fullerene (C60)-poly(2-oxazoline)s nanoformulation. Biomaterials 32, 3654-3665 (2011)
182. Viegas, T.X., et al.: Polyoxazoline: chemistry, properties, and applications in drug delivery. Bioconjug. Chem. 22, 976-986 (2011)
183. Wang, X., et al.: Synthesis, characterization and biocompatibility of poly(2-ethyl-2-oxazoline)-poly(D, L-lactide)-poly(2-ethyl-2-oxazoline) hydrogels. Acta Biomater. 7, 4149-4159 (2011)
184. Wang, C.-H., et al.: Extended release of bevaci-zumab by thermosensitive biodegradable and biocompatible hydrogel. Biomacromolecules 13, 40-48 (2012)
185. Cheon Lee, S., Kim, C., Chan Kwon, I., Chung, H., Young Jeong, S.: Polymeric micelles of poly(2- ethyl-2-oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel. J. Control. Release 89, 437-446 (2003)
186. Konradi, R., Pidhatika, B., Mühlebach, A., Textor, M.: Poly-2-methyl-2-oxazoline: a peptide-like polymer for protein-repellent surfaces. Langmuir 24, 613-616 (2008)
187. Pidhatika, B., et al.: The role of the interplay between polymer architecture and bacterial surface properties on the microbial adhesion to polyoxazoline-based ultrathin films. Biomaterials 31, 9462-9472 (2010)
188. Zhang, N., et al.: Tailored poly(2-oxazoline) polymer brushes to control protein adsorption and cell adhesion. Macromol. Biosci. 12, 926-936 (2012)
189. Wang, H., Li, L., Tong, Q., Yan, M.: Evaluation of photochemically immobilized poly(2-ethyl-2-oxazoline) thin films as protein-resistant surfaces. ACS Appl. Mater. Interfaces 3, 3463-3471 (2011)
190. Woodle, M.C., Engbers, C.M., Zalipsky, S.: New amphipathic polymer-lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes. Bioconjug. Chem. 5, 493-496 (1994)
191. Zalipsky, S., Hansen, C.B., Oaks, J.M., Allen, T.M.: Evaluation of blood clearance rates and biodistribution of poly(2-oxazoline)-grafted liposomes. J. Pharm. Sci. 85, 133-137 (1996)
192. Gaertner, F.C., Luxenhofer, R., Blechert, B., Jordan, R., Essler, M.: Synthesis, biodistribution and excretion of radiolabeled poly(2-alkyl-2-oxazoline)s. J. Control. Release 119, 291-300 (2007)
193. Goddard, P., Hutchinson, L.: Soluble polymeric carriers for drug delivery. Part 2. Preparation and in vivo behaviour of N-acylethylenimine copolymers. J. Control. Release 10, 5-16 (1989)
194. Luxenhofer, R., et al.: Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs. Biomaterials 31, 4972-4979 (2010)
195. Delgado, A.V., Gonzalez-Caballero, F., Hunter, R.J., Koopal, L.K., Lyklema, J.: Measurement and interpretation of electrokinetic phenomena. J. Colloid Interface Sci. 309, 194-224 (2007)
196. Rausch, K., Reuter, A., Fischer, K., Schmidt, M.: Evaluation of nanoparticle aggregation in human blood serum. Biomacromolecules 11, 2836-2839 (2010)
197. Olsen, S.N.: Applications of isothermal titration calorimetry to measure enzyme kinetics and activity in complex solutions. Thermochim. Acta 448, 12-18 (2006)
198. Gourishankar, A., Shukla, S., Ganesh, K.N., Sastry, M.: Isothermal titration calorimetry studies on the binding of DNA bases and PNA base monomers to gold nanoparticles. J. Am. Chem. Soc. 126, 13186-13187 (2004)
199. Cedervall, T., et al.: Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc. Natl. Acad. Sci. U. S. A. 104, 2050-2055 (2007)
200. Tenzer, S., et al.: Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 5, 7155-7167 (2011)
201. Ghoroghchian, P.P., Therien, M.J., Hammer, D.A.: In vivo fluorescence imaging: a personal perspective. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1, 156-167 (2009)
202. Herzog, H., Rösch, F.: PET- und SPECT-Technik: Chemie und Physik der Bildgebung. Pharm. Unserer Zeit 34, 468-473 (2005)
203. Herth, M.M., et al.: Radioactive labeling of defined HPMA-based polymeric structures using [18F] FETos for in vivo imaging by positron emission tomography. Biomacromolecules 10(4), 1697-1703 (2009)
204. Devaraj, N.K., Keliher, E.J., Thurber, G.M., Nahrendorf, M., Weissleder, R.: 18F labeled nanoparticles for in vivo PET-CT imaging. Bioconjugate Chem. 20, 397-401 (2009)
205. Herth, M.M., Barz, M., Jahn, M., Zentel, R., Rösch, F.: 72/74As-labeling of HPMA based polymers for long-term in vivo PET imaging. Bioorg. Med. Chem. Lett. 20, 5454-5458 (2010)
206. Fujita, Y., Taguchi, H.: Current status of multiple antigen-presenting peptide vaccine systems: application of organic and inorganic nanoparticles. Chem. Cent. J. 5, 1-8 (2011)
207. Vogel, F.R.: Immunologic adjuvants for modern vaccine formulations. Ann. N. Y. Acad. Sci. 754, 153-160 (1995)
208. Petrovsky, N., Aguilar, J.: Vaccine adjuvants: current state and future trends. Immunol. Cell Biol. 82, 488-496 (2004)
209. Panyam, J., Labhasetwar, V.: Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55, 329-347 (2003)
210. Lee, Y.-R., Lee, Y.-H., et al.: Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen. Arch. Pharm. Res. 33, 1859-1866 (2010)
211. Stone, G.W., et al.: Nanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-like receptor agonists as a treatment for melanoma. PLoS One 4, e7334 (2009)
212. Kasturi, S.P., et al.: Programming the magnitude and persistence of antibody responses with innate immunity. Nature 470, 543-547 (2011)
213. Malyala, P, O’Hagan, D.T., Singh, M.: Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles. Adv. Drug Deliv. Rev. 61, 218-225 (2009)
214. O’Hagan, D.T., Singh, M., Ulmer, J.B.: Microparticle-based technologies for vaccines. Methods 40, 10-19 (2006)
215. Sherman, M. R. et al.: Conjugation of high-molecular weight poly(ethylene glycol) to cytokines: granulocyte-macrophage colony-stimulating factors as model substrates. ACS Symposium Series, Vol. 680, pp. 155-169. (1997)
216. Alexis, F., Pridgen, E., Molnar, L.K., Farokhzad, O.C.: Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5, 505-515(2008)
217. Yang, Y., Huang, C.-T., Huang, X., Pardoll, D.M.: Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat. Immunol. 5, 508-515 (2004)
218. Galloway, A.L., et al.: Development of a nanoparticle-based influenza vaccine using the PRINT® technology. Nanomedicine 9(4), 523-531 (2013)
219. Demento, S.L., et al.: TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis. J. Immunol. 185, 2989-2997 (2010)
220. Tyagi, R.K., Garg, N.K., Sahu, T.: Vaccination strategies against malaria: novel carrier(s) more than a tour de force. J. Control. Release 162, 242-254 (2012)
221. Brandt, E.R., et al.: New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population. Nat. Med. 6, 455-459 (2000)
222. Shi, L., et al.: Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres. J. Pharm. Sci. 91, 1019-1035(2002)
223. Pejawar-Gaddy, S., et al.: Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particles. Cancer Immunol. Immunother. 59, 1685-1696 (2010)
224. Sundgren, A., Barchi, J.: Varied presentation of the Thomsen-Friedenreich disaccharide tumor-associated carbohydrate antigen on gold nanoparticles. Carbohydr. Res. 343, 1594-1604 (2008)
225. Monzavi-Karbassi, B., Pashov, A., Jousheghany, F., Artaud, C., Kieber-Emmons, T.: Evaluating strategies to enhance the anti-tumor immune response to a carbohydrate mimetic peptide vaccine. Int. J. Mol. Med. 17, 1045-1052 (2006)
226. Reddy, S., Swartz, M., Hubbell, J.: Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol. 27, 573-579 (2006)
227. Demento, S.L., et al.: Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. Vaccine 27, 3013-3021 (2009)
228. Hamdy, S., et al.: Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity. Vaccine 26, 5046-5057 (2008)
229. Barton, G.M., Medzhitov, R.: Control of adaptive immune responses by Toll-like receptors. Curr. Opin. Immunol. 14, 380-383 (2002)
230. Akagi, T., Baba, M., Akashi, M.: Biodegradable nanoparticles as vaccine adjuvants and delivery systems: regulation of immune responses by nanoparticle-based vaccine. Adv. Polym. Sci. 247, 31-64 (2011)
231. Lee, T.Y., et al.: Oral administration of poly-gamma-glutamate induces TLR4- and dendritic cell-dependent antitumor effect. Cancer Immunol Imm. 58, 1781-1794 (2009)
232. Yoshida, M., Babensee, J.E.: Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. J. Biomed. Mater. Res. A 71, 45-54(2004)
233. Tamayo, I., et al.: Poly(anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation. Clin. Vaccine Immunol. 17, 1356-1362 (2010)
234. Copland, M.J., et al.: Liposomal delivery of antigen to human dendritic cells. Vaccine 21, 883-890 (2003)
235. Matsusaki, M., et al.: Nanosphere induced gene expression in human dendritic cells. Nano Lett. 5, 2168-2173 (2005)
236. Kwon, Y.J., Standley, S.M., Goh, S.L., Fréchet, J.M.J.: Enhanced antigen presentation and immuno-stimulation of dendritic cells using acid-degradable cationic nanoparticles. J. Control. Release 105, 199-212 (2005)
237. Sun, H., Pollock, K.G.J., Brewer, J.M.: Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro. Vaccine 21, 849-855 (2003)
238. Moon, H.-J., et al.: Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus. Vet. Microbiol. 160, 277-289 (2012)
239. Geall, A., Verma, A.: Nonviral delivery of self-amplifying RNA vaccines. Proc. Natl. Acad. Sci. U. S. A. 109, 14604-14609 (2012)
240. Van den Berg, J.H., et al.: Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity. J. Control. Release 141, 234-240 (2010)
241. Varkouhi, A.K., Scholte, M., Storm, G., Haisma, H.J.: Endosomal escape pathways for delivery of biologicals. J. Control. Release 151, 220-228 (2011)
242. Krieg, A.M.: CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20, 709-760 (2002)
243. Sudowe, S., et al.: Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization. Immunology 128, e193-e205 (2009)
244. Joshi, M.D., Unger, W.J., Storm, G., Van Kooyk, Y., Mastrobattista, E.: Targeting tumor antigens to dendritic cells using particulate carriers. J. Control. Release 161, 25-37 (2012)
245. Arigita, C., et al.: Liposomal meningococcal B vaccination: role of dendritic cell targeting in the development of a protective immune response. Infect. Immun. 71, 5210-5218 (2003)
246. Espuelas, S., Haller, P., Schuber, F., Frisch, B.: Synthesis of an amphiphilic tetraantennary manno-syl conjugate and incorporation into liposome carriers. Bioorg. Med. Chem. Lett. 13, 2557-2560 (2003)
247. Espuelas, S., Thumann, C., Heurtault, B., Schuber, F., Frisch, B.: Influence of ligand valency on the targeting of immature human dendritic cells by man-nosylated liposomes. Bioconjug. Chem. 19, 2385-2393 (2008)
248. Sheng, K.-C., et al.: Delivery of antigen using a novel mannosylated dendrimer potentiates immuno-genicity in vitro and in vivo. Eur. J. Immunol. 38, 424-436 (2008)
249. Chenevier, P., et al.: Grafting of synthetic mannose receptor-ligands onto onion vectors for human dendritic cells targeting. Chem. Commun. 20, 2446-2447 (2002)
250. Saraogi, G.K., et al.: Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis. J. Drug Target. 19, 219-227 (2011)
251. Brandhonneur, N., et al.: Specific and non-specific phagocytosis of ligand-grafted PLGA microspheres by macrophages. Eur. J. Pharm. Sci. 36, 474-485 (2009)
252. Hamdy, S., Haddadi, A., Shayeganpour, A., Samuel, J., Lavasanifar, A.: Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles. Pharm. Res. 28, 2288-2301 (2011)
253. Raghuwanshi, D., Mishra, V., Suresh, M.R., Kaur, K.: A simple approach for enhanced immune response using engineered dendritic cell targeted nanoparticles. Vaccine 30, 7292-7299 (2012)
254. Fehr, T., Skrastina, D., Pumpens, P., Zinkernagel, R.M.: T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles. Proc. Natl. Acad. Sci. U. S. A. 95, 9477-9481 (1998)
255. Brinâs, R.P., et al.: Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines. Bioconjug. Chem. 23, 1513-1523 (2012)
256. Hoffmann-Röder, A., et al.: Synthetic antitumor vaccines from tetanus toxoid conjugates of MUC1 gly-copeptides with the Thomsen-Friedenreich antigen and a fluorine-substituted analogue. Angew. Chem. Int. Ed. Engl. 49, 8498-8503 (2010)
257. Gaidzik, N., et al.: Synthetic antitumor vaccines containing MUC1 glycopeptides with two immunodominant domains-induction of a strong immune response against breast tumor tissues. Angew. Chem. Int. Ed. Engl. 50, 9977-9981 (2011)
258. Cai, H., et al.: Variation of the glycosylation pattern in MUC1 glycopeptide BSA vaccines and its influence on the immune response. Angew. Chem. Int. Ed. Engl. 51, 1719-1723 (2012)